|
Real-time Estimate
Cboe BZX
17:57:33 19/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 7.310 USD | +0.69% |
|
-1.61% | -36.89% |
| 04:50pm | CorMedix Receives FDA Priority Review for Rezzayo Fungal Disease Prevention | MT |
| 09-23 | Oppenheimer Initiates CorMedix at Outperform With $15 Price Target | MT |
| Market Cap | 566M 503M 466M 424M 800M 53.71B 813M 5.6B 2.2B 28.03B 2.12B 2.08B 89.34B | P/E 2026 * |
14.7x | P/E 2027 * | 128x |
|---|---|---|---|---|---|
| Enterprise Value | 456M 406M 376M 342M 646M 43.32B 656M 4.52B 1.77B 22.61B 1.71B 1.68B 72.07B | EV / Sales 2026 * |
1.35x | EV / Sales 2027 * | 1.45x |
| Free-Float |
92.39% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CRMD | Delayed | |
CBOE
| CRMD | Real-time | |
Tradegate
| 19KA | Real-time | |
Deutsche Boerse AG
| 19KA | Delayed | |
Börse Stuttgart
| 19KA | Delayed | |
Boerse Muenchen
| 19KA | Real-time |
Last Transcript: CorMedix Inc.
| 1 day | +0.69% | ||
| 1 week | -1.61% | ||
| Current month | -4.68% | ||
| 1 month | -5.53% | ||
| 3 months | -5.66% | ||
| 6 months | -3.17% | ||
| Current year | -36.89% |
| 1 week | 7.24 | 7.7 | |
| 1 month | 7.06 | 8.18 | |
| Current year | 6.12 | 12.29 | |
| 1 year | 6.12 | 13.02 | |
| 3 years | 2.57 | 17.43 | |
| 5 years | 2.57 | 17.43 | |
| 10 years | 0.86 | 18.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Todisco
CEO | Chief Executive Officer | 50 | 10/05/2022 |
Susan Blum
DFI | Director of Finance/CFO | 54 | 29/08/2025 |
| Compliance Officer | 66 | 12/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Janet Dillione
BRD | Director/Board Member | 67 | 06/08/2015 |
Myron Kaplan
CHM | Chairman | 81 | 03/08/2017 |
Steven Lefkowitz
BRD | Director/Board Member | 70 | 16/08/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/09/26 | Exercice | Director | 97,818 | 0.1255% | ||
| 29/08/26 | Tax | Chief Financial Officer | -8,424 | 0.0108% | ||
| 29/08/26 | Tax | Compliance Officer | -8,424 | 0.0108% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.69% | -1.61% | -39.64% | +127.24% | 566M | ||
| -0.03% | +5.76% | +54.62% | +111.71% | 1,120B | ||
| -0.47% | -3.51% | +31.35% | +67.06% | 616B | ||
| +0.15% | +1.81% | +23.34% | +96.68% | 504B | ||
| +0.12% | +5.50% | +35.11% | +59.28% | 367B | ||
| +0.33% | +0.78% | +69.82% | +45.96% | 360B | ||
| -0.46% | +3.48% | +19.20% | +46.48% | 288B | ||
| -0.30% | +3.19% | -1.23% | +18.33% | 258B | ||
| +0.02% | +3.05% | +41.86% | +53.35% | 234B | ||
| +0.21% | +3.77% | +26.80% | +99.01% | 194B | ||
| Average | +0.02% | +2.82% | +26.12% | +72.51% | 394.15B | |
| Weighted average by Cap. | -0.06% | +3.52% | +38.18% | +76.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337M 300M 278M 253M 477M 31.99B 484M 3.34B 1.31B 16.69B 1.26B 1.24B 53.22B | 289M 257M 238M 217M 409M 27.45B 416M 2.86B 1.12B 14.33B 1.09B 1.06B 45.67B |
| Net income | 45.67M 40.59M 37.63M 34.23M 64.6M 4.33B 65.63M 452M 177M 2.26B 171M 168M 7.21B | 5.33M 4.74M 4.39M 3.99M 7.54M 506M 7.66M 52.78M 20.69M 264M 20M 19.58M 841M |
| Net Debt | -109M -97.26M -90.15M -82.02M -155M -10.38B -157M -1.08B -425M -5.42B -411M -402M -17.28B | -147M -131M -121M -110M -208M -13.98B -212M -1.46B -572M -7.3B -553M -541M -23.26B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/10/26 | $7.320 | +0.83% | 61,266 |
| 16/10/26 | $7.260 | -2.68% | 1,140,589 |
| 15/10/26 | $7.460 | +0.95% | 1,466,252 |
| 14/10/26 | $7.390 | 0.00% | 1,124,915 |
| 13/10/26 | $7.390 | -0.94% | 1,415,670 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRMD Stock
Select your edition
All financial news and data tailored to specific country editions

















